Related Experiment Video

Updated: Mar 23, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

945

Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab

Chad J Hruska1, Robert J Bertoli1, Yorke D Young1

  • 1University of Tennessee Graduate School of Medicine, Knoxville, Tennessee.

JAAD Case Reports
|April 7, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ALCL, anaplastic large cell lymphomaCTCL, cutaneous T-cell lymphomaHumiraLyP, lymphomatoid papulosisPCALCL, primary cutaneous anaplastic large cell lymphomaRA, rheumatoid arthritisTNF, tumor necrosis factoradalimumabanaplastic large cell lymphomacutaneous T-cell lymphomalymphomatherapeuticstumor necrosis factor-alfa

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.9K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
725